Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation
Alessio Nencioni(Ospedale Policlinico San Martino), Peter Brossart(University of Tübingen)
Cited by 132
Related Papers
Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition
|Oncotarget|2015|91
Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells
|PLoS ONE|2011|86
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice
|Thrombosis and Haemostasis|2013|50
BCR-ABL Activity Is Critical for the Immunogenicity of Chronic Myelogenous Leukemia Cells
|Cancer Research|2007|50